Exploring HERV-K (HML-2) Influence in Cancer and Prospects for Therapeutic Interventions
- PMID: 37834078
- PMCID: PMC10572383
- DOI: 10.3390/ijms241914631
Exploring HERV-K (HML-2) Influence in Cancer and Prospects for Therapeutic Interventions
Abstract
This review investigates the intricate role of human endogenous retroviruses (HERVs) in cancer development and progression, explicitly focusing on HERV-K (HML-2). This paper sheds light on the latest research advancements and potential treatment strategies by examining the historical context of HERVs and their involvement in critical biological processes such as embryonic development, immune response, and disease progression. This review covers computational modeling for drug-target binding assessment, systems biology modeling for simulating HERV-K viral cargo dynamics, and using antiviral drugs to combat HERV-induced diseases. The findings presented in this review contribute to our understanding of HERV-mediated disease mechanisms and provide insights into future therapeutic approaches. They emphasize why HERV-K holds significant promise as a biomarker and a target.
Keywords: HERV-K (HML-2); antiviral drugs; cancer; human endogenous retrovirus; viral infection.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
HIV-1 Infection of Primary CD4+ T Cells Regulates the Expression of Specific Human Endogenous Retrovirus HERV-K (HML-2) Elements.J Virol. 2017 Dec 14;92(1):e01507-17. doi: 10.1128/JVI.01507-17. Print 2018 Jan 1. J Virol. 2017. PMID: 29046457 Free PMC article.
-
p53 Binding Sites in Long Terminal Repeat 5Hs (LTR5Hs) of Human Endogenous Retrovirus K Family (HML-2 Subgroup) Play Important Roles in the Regulation of LTR5Hs Transcriptional Activity.Microbiol Spectr. 2022 Aug 31;10(4):e0048522. doi: 10.1128/spectrum.00485-22. Epub 2022 Jul 18. Microbiol Spectr. 2022. PMID: 35867400 Free PMC article.
-
Human endogenous retroviruses and cancer prevention: evidence and prospects.BMC Cancer. 2013 Jan 3;13:4. doi: 10.1186/1471-2407-13-4. BMC Cancer. 2013. PMID: 23282240 Free PMC article.
-
Human Endogenous Retrovirus K (HML-2) in Health and Disease.Front Microbiol. 2020 Jul 17;11:1690. doi: 10.3389/fmicb.2020.01690. eCollection 2020. Front Microbiol. 2020. PMID: 32765477 Free PMC article. Review.
-
Human Endogenous Retrovirus K in Cancer: A Potential Biomarker and Immunotherapeutic Target.Viruses. 2020 Jul 6;12(7):726. doi: 10.3390/v12070726. Viruses. 2020. PMID: 32640516 Free PMC article. Review.
Cited by
-
Exploring transposable elements: new horizons in cancer diagnostics and therapeutics.Mob DNA. 2025 Jul 12;16(1):28. doi: 10.1186/s13100-025-00366-9. Mob DNA. 2025. PMID: 40646624 Free PMC article. Review.
-
Cancer Treatment: New Drugs and Strategies.Int J Mol Sci. 2024 Sep 16;25(18):9976. doi: 10.3390/ijms25189976. Int J Mol Sci. 2024. PMID: 39337464 Free PMC article.
-
Human Endogenous Retroviruses as Novel Therapeutic Targets in Neurodegenerative Disorders.Vaccines (Basel). 2025 Apr 15;13(4):415. doi: 10.3390/vaccines13040415. Vaccines (Basel). 2025. PMID: 40333317 Free PMC article. Review.
-
Editorial: The evolution, characterization, and role of human endogenous retroviruses in health and diseases.Front Cell Infect Microbiol. 2024 Jul 8;14:1449864. doi: 10.3389/fcimb.2024.1449864. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39040603 Free PMC article. No abstract available.
-
Activation of APOBEC3 cytidine deaminases and endogenous retroviruses is integrated by MUC1-C in NSCLC cells.Cell Death Discov. 2025 Aug 8;11(1):372. doi: 10.1038/s41420-025-02673-9. Cell Death Discov. 2025. PMID: 40781226 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical